Bryan McIver

17.6k total citations · 4 hit papers
90 papers, 11.9k citations indexed

About

Bryan McIver is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Bryan McIver has authored 90 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Endocrinology, Diabetes and Metabolism, 31 papers in Genetics and 29 papers in Surgery. Recurrent topics in Bryan McIver's work include Thyroid Cancer Diagnosis and Treatment (60 papers), BRCA gene mutations in cancer (22 papers) and Thyroid and Parathyroid Surgery (17 papers). Bryan McIver is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (60 papers), BRCA gene mutations in cancer (22 papers) and Thyroid and Parathyroid Surgery (17 papers). Bryan McIver collaborates with scholars based in United States, New Zealand and United Kingdom. Bryan McIver's co-authors include Steven I. Sherman, Ernest L. Mazzaferri, Susan J. Mandel, Bryan R. Haugen, R. Michael Tuttle, Richard T. Kloos, Stephanie L. Lee, David S. Cooper, Gerard M. Doherty and Martin Schlumberger and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Bryan McIver

89 papers receiving 11.5k citations

Hit Papers

Revised American Thyroid Association Management Guideline... 2002 2026 2010 2018 2009 2006 2008 2002 1000 2.0k 3.0k 4.0k 5.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
    2009 5.1k citations David S. Cooper, Gerard M. Doherty et al. Thyroid profile →
  2. Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
    2006 1.5k citations David S. Cooper, Bryan R. Haugen et al. Thyroid profile →
  3. Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period
    2008 578 citations Bryan McIver, Clive S. Grant et al. profile →
  4. Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long‐term Outcome in 2444 Consecutively Treated Patients
    2002 546 citations Ian Hay, Geoffrey B. Thompson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan McIver United States 39 10.3k 6.0k 1.8k 1.4k 1.3k 90 11.9k
Akihiro Miya Japan 51 8.6k 0.8× 5.8k 1.0× 1.3k 0.7× 1.4k 1.0× 1.4k 1.0× 252 10.5k
Young Kee Shong South Korea 54 9.4k 0.9× 5.1k 0.8× 1.2k 0.7× 1.2k 0.8× 1.6k 1.2× 311 11.0k
Sally E. Carty United States 50 5.5k 0.5× 4.2k 0.7× 1.8k 1.0× 1.1k 0.8× 1.5k 1.1× 189 9.1k
Richard T. Kloos United States 44 13.7k 1.3× 8.3k 1.4× 2.0k 1.1× 2.5k 1.7× 1.8k 1.3× 111 16.8k
Zubair Baloch United States 59 10.9k 1.1× 8.0k 1.3× 2.0k 1.1× 1.6k 1.1× 2.9k 2.1× 322 15.7k
Paolo Miccoli Italy 65 9.3k 0.9× 7.3k 1.2× 1.8k 1.0× 2.4k 1.7× 3.0k 2.2× 390 15.1k
Fumio Matsuzuka Japan 52 5.9k 0.6× 4.0k 0.7× 898 0.5× 1.6k 1.1× 1.2k 0.9× 228 8.7k
Stephanie L. Lee United States 22 7.3k 0.7× 4.6k 0.8× 857 0.5× 665 0.5× 694 0.5× 66 8.7k
Steven G. Waguespack United States 46 5.4k 0.5× 3.5k 0.6× 1.2k 0.7× 1.2k 0.8× 1.7k 1.3× 173 8.4k
Allan Siperstein United States 57 4.2k 0.4× 5.5k 0.9× 1.1k 0.6× 824 0.6× 2.6k 1.9× 262 10.3k

Countries citing papers authored by Bryan McIver

Since Specialization
Citations

This map shows the geographic impact of Bryan McIver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan McIver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan McIver more than expected).

Fields of papers citing papers by Bryan McIver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan McIver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan McIver. The network helps show where Bryan McIver may publish in the future.

Co-authorship network of co-authors of Bryan McIver

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan McIver. A scholar is included among the top collaborators of Bryan McIver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan McIver. Bryan McIver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hicks, J. Kevin, Rachel Howard, Jacob J. Adashek, et al.. (2021). Integrating Somatic and Germline Next-Generation Sequencing Into Routine Clinical Oncology Practice. JCO Precision Oncology. 5(5). 884–895. 31 indexed citations
2.
Valderrábano, Pablo, Laila Khazai, Zachary Thompson, et al.. (2017). Cancer Risk Stratification of Indeterminate Thyroid Nodules: A Cytological Approach. Thyroid. 27(10). 1277–1284. 28 indexed citations
3.
Valderrábano, Pablo, Marino E. Leon, Barbara A. Centeno, et al.. (2016). Institutional prevalence of malignancy of indeterminate thyroid cytology is necessary but insufficient to accurately interpret molecular marker tests. European Journal of Endocrinology. 174(5). 621–629. 44 indexed citations
4.
Valderrábano, Pablo, Victor Zota, Bryan McIver, Domenico Coppola, & Marino E. Leon. (2015). Molecular Assays in Cytopathology for Thyroid Cancer. Cancer Control. 22(2). 152–157. 9 indexed citations
5.
Finlayson, Alexander, et al.. (2014). Incidence of thyroid cancer in England by ethnic group, 2001–2007. British Journal of Cancer. 110(5). 1322–1327. 22 indexed citations
6.
7.
8.
9.
Fatourechi, Mitra M., Ian Hay, Bryan McIver, Thomas J. Sebo, & Vahab Fatourechi. (2011). Invasive Fibrous Thyroiditis (Riedel Thyroiditis): The Mayo Clinic Experience, 1976–2008. Thyroid. 21(7). 765–772. 77 indexed citations
10.
Reddi, Honey V., Dragana Milosevic, Jennifer S. Hackbarth, et al.. (2011). The Putative PAX8/PPAR  Fusion Oncoprotein Exhibits Partial Tumor Suppressor Activity through Up-Regulation of Micro-RNA-122 and Dominant-Negative PPAR  Activity. Genes & Cancer. 2(1). 46–55. 27 indexed citations
11.
Foote, Robert L., Julian R. Molina, Jan L. Kasperbauer, et al.. (2010). Enhanced Survival in Locoregionally Confined Anaplastic Thyroid Carcinoma: A Single-Institution Experience Using Aggressive Multimodal Therapy. Thyroid. 21(1). 25–30. 110 indexed citations
12.
Bible, Keith C., Vera J. Suman, Julian R. Molina, et al.. (2010). Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study. The Lancet Oncology. 11(10). 962–972. 330 indexed citations
13.
Marlow, Laura A., Lisa A. Reynolds, Simon Cooper, et al.. (2009). Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth. Cancer Research. 69(4). 1536–1544. 60 indexed citations
14.
Cooper, David S., Gerard M. Doherty, Bryan R. Haugen, et al.. (2009). Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 19(11). 1167–1214. 5125 indexed citations breakdown →
15.
Eberhardt, Norman L., Stefan K. Grebe, Bryan McIver, & Honey V. Reddi. (2009). The role of the PAX8/PPARγ fusion oncogene in the pathogenesis of follicular thyroid cancer. Molecular and Cellular Endocrinology. 321(1). 50–56. 72 indexed citations
16.
Reddi, Honey V., et al.. (2008). The Role of the PAX8/PPARγ Fusion Oncogene in Thyroid Cancer. PPAR Research. 2008(1). 672829–672829. 45 indexed citations
17.
Şahi̇n, Mustafa, Shaohua Wang, Ian Hay, et al.. (2004). The PAX8/PPARγ fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type PPARγ inhibition. Oncogene. 23(20). 3634–3641. 79 indexed citations
18.
Velickovic, Marija, Brett Delahunt, Bryan McIver, & Stefan K. Grebe. (2002). Intragenic PTEN/MMAC1 Loss of Heterozygosity in Conventional (Clear-Cell) Renal Cell Carcinoma is Associated with Poor Patient Prognosis. Modern Pathology. 15(5). 479–485. 59 indexed citations
19.
Spitzweg, Christine, Shaobo Zhang, Elizabeth R. Bergert, et al.. (1999). Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.. PubMed. 59(9). 2136–41. 154 indexed citations
20.
McIver, Bryan, et al.. (1991). Adipsic hypothalamic diabetes insipidus after clipping of anterior communicating artery aneurysm.. BMJ. 303(6815). 1465–1467. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akihiro Miya Breakdown of academic impact, for papers by Young Kee Shong Breakdown of academic impact, for papers by Sally E. Carty Breakdown of academic impact, for papers by Richard T. Kloos Breakdown of academic impact, for papers by Zubair Baloch Breakdown of academic impact, for papers by Paolo Miccoli Breakdown of academic impact, for papers by Fumio Matsuzuka Breakdown of academic impact, for papers by Stephanie L. Lee Breakdown of academic impact, for papers by Steven G. Waguespack Breakdown of academic impact, for papers by Allan Siperstein
Rankless by CCL
2026